Safety and Efficacy of Multiple Escalating Doses of RC28-E for Neovascular Age-Related Macular Degeneration: A Phase 1b Trial
Ophthalmology and Therapy(2024)
Key words
Age-related macular degeneration,RC28-E,Anti-VEGF agent,Fibroblast growth factor,Clinical trial
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined